Tove Olafsen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Magnetic Resonance

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics 23 (6) (2024)
Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics 23 (6) (2024)
Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics 23 (6) (2024)
Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics (2024)